-
Treatment challenges in MIBC: ctDNA, EV-P cost and access
November 15, 2025In his EMUC25 lecture ‘ctDNA in muscle-invasive bladder cancer: Ready for prime time?’ Prof. Lars Dyrskjøt (DK) shared data...
00 -
Personalised approaches to treating GU cancers
November 27, 2021Personalised approaches such as the use of circulating tumour DNA (ctDNA) biomarkers and genetic testing is the way to...
-
EMUC18 addresses current dilemmas in mPCa treatment
November 12, 2018What is the role of cell-free circulating tumour DNA (ctDNA) in the treatment of metastatic prostate cancer (mPCa)? How...
